Novartis, Pfizer join forces on potentially lucrative fatty liver disease

Novartis AG and Pfizer Inc are teaming up to develop treatments for a liver disease many drug companies believe will become a hugely lucrative market, as it is tied to the obesity and diabetes epidemics.

https://ift.tt/2z9V1EI support@endlesssupplies.biz (Endless Supplies .Biz) October 29, 2018 at 01:51AM